Paychex (PAYX) Could Be 37% Undervalued On Its WISE AI Rollout

Paychex (PAYX) stock is drawing fresh attention after the company rolled out its AI engine WISE into Microsoft 365 Copilot and Teams, weaving workforce insights directly into widely used business productivity tools.

See our latest analysis for Paychex.

The WISE integration arrives after a run of stronger momentum in Paychex’s share price, including a 1-month share price return of 11.11% and a 90-day share price return of 27.89%. This comes even though the 1-year total shareholder return is down 10.75%, and longer term 3-year and 5-year total shareholder returns of 7.03% and 20.41% suggest a slower build in value over time.

If the AI push from Paychex has your attention, it may be a good moment to scan other AI focused opportunities using our small cap screener 30 AI small caps

The recent jump in Paychex, alongside a headline discount to some fair value estimates and analyst targets, leaves a split view. Is the market rightly cautious on this AI story, or has price lagged fundamentals?

Most Popular Narrative: 9.6% Overvalued

The most followed Paychex valuation narrative pegs fair value at $109.57, which sits below the last close of $120.13 and presents the recent AI excitement in a more measured way.

The analysts have a consensus price target of $109.57 for Paychex based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $150.0, and the most bearish reporting a price target of just $95.0.

Read the complete narrative.

Want to understand why Paychex might justify a higher valuation despite this apparent gap? The narrative refers to steady revenue expansion, richer margins and a future earnings multiple that may need to compress. It raises the question of which specific growth and profitability assumptions are carrying most of that weight. The full story sits inside those projections.

Result: Fair Value of $109.57 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Paychex still faces real execution tests, including Paycor integration risk and pressure on margins if clients continue trading down to lower cost benefit plans.

Find out about the key risks to this Paychex narrative.

Another View On Paychex: Cash Flow Points The Other Way

The analyst narrative frames Paychex as 9.6% overvalued at $120.13 compared with a fair value of $109.57. Our DCF model tells a very different story. On that measure, Paychex screens as undervalued, with the current $120.13 price sitting 36.8% below an estimated value of $190.15.

This gap places investors between two opposing signals. One view leans on earnings forecasts and P/E assumptions, while the SWS DCF model focuses on future cash flows. Which lens feels more reliable for the way you assess risk and opportunity over the next few years?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Paychex for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The mixed signals around Paychex can feel confusing, so treat them as a prompt to review the evidence and decide where you stand. To weigh both the concerns and the upside in one place, take a closer look at the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Paychex?

If Paychex has sharpened your focus on quality, do not stop there. Broader research across different styles of opportunities can help you build a stronger watchlist.

Use the Simply Wall Street Screener to quickly surface ideas that match your goals, and avoid missing companies that quietly fit what you are looking for.

• Target resilient compounders by scanning companies with strong finances and low perceived risk through the 78 resilient stocks with low risk scores.
• Hunt for potential value by reviewing companies that combine quality fundamentals with attractive pricing in the 50 high quality undervalued stocks.
• Spot potential early stage opportunities by searching for financially stronger smaller companies in the 20 elite penny stocks with strong financials.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com